JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.9% |
| 2 | Financials | 12.36% |
| 3 | Healthcare | 9.31% |
| 4 | Consumer Discretionary | 8.69% |
| 5 | Industrials | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JPUS
3776
JPMorgan Diversified Return US Equity ETF
JPUS
$469M
| $887K | ﹤0.01% |
11,930
-55
| -0.5% | -$4.06K |
|
3777
International Seaways
INSW
$4.82B
| $886K | ﹤0.01% |
46,601
-22,094
| -32% | -$409K |
|
3778
Standex International
SXI
$4B
| $885K | ﹤0.01% |
12,215
-3,520
| -22% | -$249K |
|
3779
Vanguard Consumer Staples ETF
VDC
$8.04B
| $880K | ﹤0.01% |
5,921
+3,453
| +140% | +$509K |
|
|
SBBX
3780
DELISTED
SB One Bancorp Common Stock
SBBX
| $877K | ﹤0.01% |
39,299
+27,223
| +225% | +$614K |
|
3781
Enel Chile
ENIC
$6.2B
| $876K | ﹤0.01% |
184,803
-112,870
| -38% | -$542K |
|
|
AKCA
3782
PUT
DELISTED
Akcea Therapeutics Inc
AKCA
| $874K | ﹤0.01% |
37,800
+12,800
| +51% | +$316K |
|
|
WNS
3783
DELISTED
WNS Holdings
WNS
| $873K | ﹤0.01% |
14,804
-8,330
| -36% | -$468K |
|
|
MRTX
3784
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $871K | ﹤0.01% |
8,330
+449
| +6% | +$35K |
|
3785
Aclaris Therapeutics
ACRS
$846M
| $870K | ﹤0.01% |
408,262
+162,458
| +66% | +$885K |
|
3786
PUT
Franklin Resources
BEN
$17.2B
| $868K | ﹤0.01% |
+25,000
| New | +$850K |
|
3787
Star Bulk Carriers
SBLK
$3.24B
| $863K | ﹤0.01% |
94,054
-152,025
| -62% | -$1.22M |
|
3788
CALL
NOV
NOV
$7.56B
| $857K | ﹤0.01% |
40,000
| – | – |
|
|
VNTR
3789
DELISTED
Venator Materials PLC
VNTR
| $854K | ﹤0.01% |
160,249
-37,997
| -19% | -$207K |
|
3790
CALL
PACCAR
PCAR
$68.8B
| $848K | ﹤0.01% |
+18,000
| New | +$836K |
|
3791
Rogers Corp
ROG
$2.54B
| $848K | ﹤0.01% |
5,117
+657
| +15% | +$107K |
|
|
OSB
3792
DELISTED
Norbord Inc.
OSB
| $848K | ﹤0.01% |
34,482
-8,568
| -20% | -$202K |
|
3793
Noodles & Co
NDLS
$110M
| $847K | ﹤0.01% |
14,162
+13,404
| +1,768% | +$775K |
|
3794
Orion Group Holdings
ORN
$401M
| $847K | ﹤0.01% |
360,317
+267,828
| +290% | +$665K |
|
|
ABB
3795
DELISTED
ABB Ltd
ABB
| $842K | ﹤0.01% |
42,175
-1,665,433
| -98% | -$32.4M |
|
|
SMTA
3796
DELISTED
Spirit MTA REIT Common Shares of Beneficial Interest
SMTA
| $842K | ﹤0.01% |
101,270
+35,528
| +54% | +$262K |
|
|
GSS
3797
DELISTED
Golden Star Resources Ltd.
GSS
| $840K | ﹤0.01% |
212,147
+34,506
| +19% | +$135K |
|
3798
Lindsay Corp
LNN
$1.17B
| $839K | ﹤0.01% |
10,340
+1,521
| +17% | +$127K |
|
|
ELGX
3799
DELISTED
Endologix Inc
ELGX
| $838K | ﹤0.01% |
114,768
+102,807
| +860% | +$701K |
|
|
DHIL
3800
DELISTED
Diamond Hill
DHIL
| $836K | ﹤0.01% |
5,990
+1,102
| +23% | +$157K |
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,669 increased, 2,117 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.